News

We're thrilled to share the latest developments from our company.

Suche

Report from the Extraordinary General Meeting

Today, 26 June 2025, an Extraordinary General Meeting was held in ODI Pharma AB (publ), reg. no. 559223-1392. Below is a summary of the...

ODI Pharma

26. Juni2 Min. Lesezeit

Stämmokommuniké från extra bolagsstämma i ODI Pharma AB (publ)

Idag, den 26 juni 2025, hölls en extra bolagsstämma i ODI Pharma AB (publ), org.nr 559223-1392. Nedan följer en sammanfattning av de...

ODI Pharma

26. Juni2 Min. Lesezeit

Kallelse till extra bolagsstämma i ODI Pharma AB (publ)

Aktieägarna i ODI Pharma AB (publ), 559223-1392, kallas härmed till extra bolagsstämma torsdagen den 26 juni 2025 kl. 14.30 i bolagets...

ODI Pharma

10. Juni6 Min. Lesezeit

Notice of Extraordinary General Meeting in ODI Pharma AB (publ)

The shareholders of ODI Pharma AB (publ), 559223-1392, are hereby invited to an Extraordinary General Meeting to be held on Thursday 26...

ODI Pharma

10. Juni8 Min. Lesezeit

ODI Pharma proposes directed share issue of approximately SEK 2.0 million

The Board of Directors of ODI Pharma AB (publ) (“ODI Pharma” or the “Company”) has resolved to propose a directed share issue of...

ODI Pharma

9. Juni4 Min. Lesezeit

Publication of interim report Q3 2024/2025

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2024 - March 2025. The report is available...

ODI Pharma

29. Mai2 Min. Lesezeit

Publication of half-year report 2024/2025

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July 2024 – December 2024. The report is...

ODI Pharma

27. Feb.3 Min. Lesezeit

ODI Pharma terminates the agreement with liquidity provider

ODI Pharma AB ("ODI Pharma") hereby informs the termination of the agreement regarding the liquidity provider with Pareto Securities AB....

ODI Pharma

16. Jan.1 Min. Lesezeit

Announcement from the Annual General Meeting in ODI Pharma AB (publ)

Today, the 30th of December 2024, ODI Pharma AB (publ) held its Annual General Meeting (“AGM”). A summary of the resolutions follows...

ODI Pharma

30. Dez. 20243 Min. Lesezeit

Kommuniké från årsstämma i ODI Pharma AB (publ)

Idag den 30 december 2024 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...

ODI Pharma

30. Dez. 20242 Min. Lesezeit

ODI Pharma AB announces last day of trading in BTA

ODI Pharma AB’s ("ODI" or the "Company") preferential issue of shares, with a subscription period ending on December 10, 2024, has now...

ODI Pharma

19. Dez. 20244 Min. Lesezeit

Flagging notification

ODI Pharma AB ("ODI Pharma") hereby informs that the current CEO, Derek Simmross, did not subscribe to his pro-rata in the completed...

ODI Pharma

13. Dez. 20241 Min. Lesezeit

ODI Pharma AB publishes outcome of rights issue

The subscription period in ODI Pharma AB’s ("ODI" or the "Company") issue of shares with preferential right (the “Rights Issue”) ended on...

ODI Pharma

11. Dez. 20244 Min. Lesezeit

ODI Pharma achieved market share targets in 2024 and increases its targets for 2025. Positioned for growth as Poland's medical cannabis market expands

O DI Pharma AB ("ODI" or the "Company") provides an update on Poland’s expanding medical cannabis market, which remains an important...

ODI Pharma

4. Dez. 20242 Min. Lesezeit

ODI Pharma AB publishes the annual report for the fiscal year 2023/2024

The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...

ODI Pharma

2. Dez. 20242 Min. Lesezeit

ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2023/2024

Styrelsen och verkställande direktören för ODI Pharma AB ("ODI Pharma") publicerar härmed årsredovisningen för räkenskapsåret 2023/2024....

ODI Pharma

2. Dez. 20241 Min. Lesezeit

Notice to Annual General Meeting in ODI Pharma AB (publ)

The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Monday, 30th of...

ODI Pharma

27. Nov. 20245 Min. Lesezeit

Kallelse till årsstämma i ODI Pharma AB (publ)

Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma måndagen den 30 december 2024 kl. 10:00 i bolagets lokaler...

ODI Pharma

27. Nov. 20244 Min. Lesezeit

The subscription period in ODI Pharma AB’s preferential rights issue commences today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA,...

ODI Pharma

26. Nov. 20247 Min. Lesezeit

ODI Pharma AB publishes memorandum prior to preferential rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA,...

ODI Pharma

25. Nov. 20244 Min. Lesezeit